SIA
DGX icon

Strategic Investment Advisors’s Quest Diagnostics DGX Stock Holding History

Strategic Investment Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,713
Closed -$1.33M – 191
2021
Q4 		$1.33M Buy
+7,713
New +$1.17M 0.26% 70

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Strategic Investment Advisors's DGX Position: Q1 2022 in Review

Strategic Investment Advisors sold out of Quest Diagnostics (DGX) in Q1 2022, closing a stake of 7,713 shares — an estimated $1.33M sold.

Strategic Investment Advisors first reported a position in DGX in Q4 2021 and held it in 1 quarter. The position peaked at $1.33M in Q4 2021. 852 funds tracked by Wall St. Rank hold DGX as of Q1 2022.

  • Strategic Investment Advisors reported no remaining Quest Diagnostics position as of Q1 2022 after selling out during the quarter.
  • Strategic Investment Advisors sold 7,713 Quest Diagnostics shares in Q1 2022, an estimated $1.33M.
  • Strategic Investment Advisors first reported a position in Quest Diagnostics in Q4 2021 and held it in 1 quarter.
  • Strategic Investment Advisors's Quest Diagnostics position peaked at $1.33M in Q4 2021.
  • 852 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.

Based on Strategic Investment Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.